PL2225271T3 - Nowe nieselektywne analogi somatostatyny - Google Patents
Nowe nieselektywne analogi somatostatynyInfo
- Publication number
- PL2225271T3 PL2225271T3 PL08856519T PL08856519T PL2225271T3 PL 2225271 T3 PL2225271 T3 PL 2225271T3 PL 08856519 T PL08856519 T PL 08856519T PL 08856519 T PL08856519 T PL 08856519T PL 2225271 T3 PL2225271 T3 PL 2225271T3
- Authority
- PL
- Poland
- Prior art keywords
- new non
- somatostatin analogues
- selective somatostatin
- selective
- analogues
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/655—Somatostatins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
- A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/655—Somatostatins
- C07K14/6555—Somatostatins at least 1 amino acid in D-form
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Endocrinology (AREA)
- Toxicology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Immunology (AREA)
- Urology & Nephrology (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Diabetes (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Ophthalmology & Optometry (AREA)
- Pain & Pain Management (AREA)
- Vascular Medicine (AREA)
- Transplantation (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ITMI20072266 ITMI20072266A1 (it) | 2007-12-03 | 2007-12-03 | Nuovi analoghi non selettivi di somatostatina |
EP07425778A EP2067786A1 (en) | 2007-12-07 | 2007-12-07 | Novel non selective analogs of somatostatin |
EP08856519.7A EP2225271B1 (en) | 2007-12-03 | 2008-11-24 | New non-selective somatostatin analogues |
PCT/EP2008/066081 WO2009071460A2 (en) | 2007-12-03 | 2008-11-24 | New non-selective somatostatin analogues |
Publications (1)
Publication Number | Publication Date |
---|---|
PL2225271T3 true PL2225271T3 (pl) | 2013-12-31 |
Family
ID=40667736
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL08856519T PL2225271T3 (pl) | 2007-12-03 | 2008-11-24 | Nowe nieselektywne analogi somatostatyny |
Country Status (15)
Country | Link |
---|---|
US (1) | US8937152B2 (pl) |
EP (1) | EP2225271B1 (pl) |
JP (1) | JP5331817B2 (pl) |
KR (1) | KR101500528B1 (pl) |
CN (1) | CN101883785B (pl) |
BR (1) | BRPI0818978B8 (pl) |
CA (1) | CA2702940C (pl) |
CY (1) | CY1114490T1 (pl) |
DK (1) | DK2225271T3 (pl) |
ES (1) | ES2431573T3 (pl) |
HR (1) | HRP20130948T1 (pl) |
PL (1) | PL2225271T3 (pl) |
PT (1) | PT2225271E (pl) |
SI (1) | SI2225271T1 (pl) |
WO (1) | WO2009071460A2 (pl) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101730708B (zh) | 2007-03-28 | 2013-09-18 | 哈佛大学校长及研究员协会 | 缝合多肽 |
CA2702940C (en) * | 2007-12-03 | 2016-09-13 | Andrea Vitali | New non-selective somatostatin analogues |
SI2603600T1 (sl) | 2010-08-13 | 2019-04-30 | Aileron Therapeutics, Inc. | Peptidomimetični makrocikli |
CN106146649B (zh) * | 2011-09-04 | 2020-09-01 | 株式会社糖锁工学研究所 | 附加糖链的多肽和含有该多肽的医药组合物 |
WO2013059525A1 (en) | 2011-10-18 | 2013-04-25 | Aileron Therapeutics, Inc. | Peptidomimetic macrocyles |
SG11201404648PA (en) | 2012-02-15 | 2014-09-26 | Aileron Therapeutics Inc | Peptidomimetic macrocycles |
CN108912211A (zh) | 2012-02-15 | 2018-11-30 | 爱勒让治疗公司 | 三唑交联的和硫醚交联的拟肽大环化合物 |
EP2914256B1 (en) | 2012-11-01 | 2019-07-31 | Aileron Therapeutics, Inc. | Disubstituted amino acids and methods of preparation and use thereof |
DK3007704T3 (da) * | 2013-06-13 | 2021-03-29 | Antisense Therapeutics Ltd | Kombinationsterapi til akromegali |
CN103467575B (zh) * | 2013-08-22 | 2016-03-02 | 深圳翰宇药业股份有限公司 | 一种帕西瑞肽的制备方法 |
CN103641894B (zh) * | 2013-12-06 | 2015-10-28 | 深圳翰宇药业股份有限公司 | 一种治疗库欣病的多肽药物的制备方法 |
EP3197478A4 (en) | 2014-09-24 | 2018-05-30 | Aileron Therapeutics, Inc. | Peptidomimetic macrocycles and uses thereof |
CN104447962B (zh) * | 2014-12-29 | 2018-07-17 | 成都圣诺生物科技股份有限公司 | 一种合成帕瑞肽的方法 |
US10253067B2 (en) | 2015-03-20 | 2019-04-09 | Aileron Therapeutics, Inc. | Peptidomimetic macrocycles and uses thereof |
US20210346527A1 (en) * | 2018-09-25 | 2021-11-11 | Advanced Accelerator Applications (Italy) Srl | Combination Therapy |
GB201816637D0 (en) | 2018-10-12 | 2018-11-28 | Heptares Therapeutics Ltd | Selective somatostatin receptor agonists |
IT202100032615A1 (it) | 2021-12-24 | 2023-06-24 | Italfarmaco Spa | Uso di un agonista della somatostatina nel trattamento di tumori che esprimono SSTR3 |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MY147327A (en) * | 1995-06-29 | 2012-11-30 | Novartis Ag | Somatostatin peptides |
GB0018891D0 (en) | 2000-08-01 | 2000-09-20 | Novartis Ag | Organic compounds |
US6365380B2 (en) * | 2000-02-23 | 2002-04-02 | Pcbu Services, Inc. | Method for stereoselectively inverting a chiral center of a chemical compound using an enzyme and a metal catalyst |
WO2003077878A1 (en) * | 2002-03-12 | 2003-09-25 | The Procter & Gamble Company | Cosmetic composition comprising double coated pigment |
GB0206415D0 (en) | 2002-03-19 | 2002-05-01 | Glaxo Group Ltd | Deracemisation of amines |
GB0300095D0 (en) * | 2003-01-03 | 2003-02-05 | Novartis Ag | Organic compounds |
PE20050285A1 (es) * | 2003-06-24 | 2005-06-09 | Novartis Ag | Composicion farmaceutica que comprende analogos ciclicos de somatostatina |
JP2007501775A (ja) * | 2003-08-07 | 2007-02-01 | ノバルティス アクチエンゲゼルシャフト | 免疫抑制剤としてのヒストンデアセチラーゼ阻害剤 |
GB0318682D0 (en) | 2003-08-08 | 2003-09-10 | Novartis Ag | Organic compounds |
EP1522311A1 (fr) * | 2003-10-10 | 2005-04-13 | Institut National De La Sante Et De La Recherche Medicale (Inserm) | Utilisation de la somatostine ou d'un de ses analogues pour préparer un médicament destiné à réguler la réserve folliculaire ovarienne chez la femme non ménopausée |
JP2007518702A (ja) * | 2003-11-25 | 2007-07-12 | ノバルティス アクチエンゲゼルシャフト | ソマトスタチン類似体処置の効力についてのバイオマーカー |
ITFI20040057A1 (it) * | 2004-03-10 | 2004-06-10 | Mauro Giuntini | Analoghi della somatostatina |
GB0428151D0 (en) | 2004-12-22 | 2005-01-26 | Novartis Ag | Organic compounds |
US7824663B2 (en) * | 2005-03-10 | 2010-11-02 | Kokyu Alcohol Kogyo Co., Ltd. | Lip gloss composition |
PT1787658E (pt) * | 2005-11-10 | 2012-06-22 | Chemi Spa | Formulações de libertação sustentada de análogos de somatostatina inibidores da hormona do crescimento |
CA2702940C (en) * | 2007-12-03 | 2016-09-13 | Andrea Vitali | New non-selective somatostatin analogues |
-
2008
- 2008-11-24 CA CA2702940A patent/CA2702940C/en active Active
- 2008-11-24 DK DK08856519.7T patent/DK2225271T3/da active
- 2008-11-24 EP EP08856519.7A patent/EP2225271B1/en active Active
- 2008-11-24 ES ES08856519T patent/ES2431573T3/es active Active
- 2008-11-24 PL PL08856519T patent/PL2225271T3/pl unknown
- 2008-11-24 JP JP2010535349A patent/JP5331817B2/ja active Active
- 2008-11-24 BR BRPI0818978A patent/BRPI0818978B8/pt active IP Right Grant
- 2008-11-24 KR KR1020107010880A patent/KR101500528B1/ko active IP Right Grant
- 2008-11-24 US US12/734,475 patent/US8937152B2/en active Active
- 2008-11-24 PT PT88565197T patent/PT2225271E/pt unknown
- 2008-11-24 CN CN200880118937.1A patent/CN101883785B/zh active Active
- 2008-11-24 WO PCT/EP2008/066081 patent/WO2009071460A2/en active Application Filing
- 2008-11-24 SI SI200831046T patent/SI2225271T1/sl unknown
-
2013
- 2013-10-07 HR HRP20130948AT patent/HRP20130948T1/hr unknown
- 2013-10-10 CY CY20131100895T patent/CY1114490T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
BRPI0818978A2 (pt) | 2016-05-03 |
KR20100103464A (ko) | 2010-09-27 |
KR101500528B1 (ko) | 2015-03-09 |
WO2009071460A2 (en) | 2009-06-11 |
CA2702940A1 (en) | 2009-06-11 |
SI2225271T1 (sl) | 2013-10-30 |
HRP20130948T1 (hr) | 2013-11-08 |
EP2225271B1 (en) | 2013-07-31 |
CN101883785A (zh) | 2010-11-10 |
US8937152B2 (en) | 2015-01-20 |
JP2011505345A (ja) | 2011-02-24 |
WO2009071460A3 (en) | 2009-12-17 |
JP5331817B2 (ja) | 2013-10-30 |
BRPI0818978B1 (pt) | 2019-09-10 |
ES2431573T3 (es) | 2013-11-27 |
DK2225271T3 (da) | 2013-10-07 |
PT2225271E (pt) | 2013-09-27 |
BRPI0818978B8 (pt) | 2021-05-25 |
CY1114490T1 (el) | 2016-10-05 |
US20100323964A1 (en) | 2010-12-23 |
CA2702940C (en) | 2016-09-13 |
EP2225271A2 (en) | 2010-09-08 |
CN101883785B (zh) | 2014-01-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SI2225271T1 (sl) | Novi selektivni analogi somatostatina | |
HK1203531A1 (en) | Glucagon analogues | |
ZA201104592B (en) | Glucagon analogues | |
ZA201104593B (en) | Glucagon analogues | |
ZA201104591B (en) | Glucagon analogues | |
IL195730A0 (en) | New pyridine analogues | |
IL202550A0 (en) | Heteroaryl amide analogues | |
IL204066A (en) | קומפלקסים של peg שיוצרו באמצעות שיטת dnl ושימושיהן | |
ZA200810646B (en) | New pyridine analogues | |
HK1146064A1 (en) | Oxytocin analogues | |
EP1841430A4 (en) | SUBSTITUTED PYRIDAZINYL AND PYRIMIDINYL-CHINOLIN-4-YLAMINE ANALOGUE | |
IL195981A0 (en) | New pyridine analogues | |
ZA200810647B (en) | New pyridine analogues | |
IL195982A0 (en) | New pyridine analogues | |
EP2197879A4 (en) | CAMPTOTHECIN ANALOGUES SUBSTITUTED IN C7 | |
HK1156630A1 (en) | Schweinfurthin analogues schweinfurthin | |
GB0710295D0 (en) | Handrails | |
GB0723556D0 (en) | Handrail | |
EP2197279A4 (en) | C10-SUBSTITUTED CAMPTOTHECIN ANALOG | |
BRPI0920777A2 (pt) | análogos de somatostatina | |
GB0808400D0 (en) | Somatostatin | |
GB0711673D0 (en) | Glucagon analogues | |
ZA200810422B (en) | New pyridine analogues | |
ZA200810645B (en) | New pyridine analogues | |
TWI350593B (en) | Fast recovery rectifiers |